Changes in urine composition after trauma facilitate bacterial growth

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Aubron, Cecile ^a   Huet, Olivier ^b   Ricome, Sylvie ^b   Borderie, Didier ^c   Pussard, Eric ^b   Leblanc, Pierre Etienne ^b   Bouvet, Odile ^a   Vicaut, Eric ^a   Denamur, Erick ^a   Duranteau, Jacques ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICÊTRE HOSPITAL   (France)

^c Assistance Publique Hôpitaux de Paris and Université Paris 5 ^*  (France)

Author keywords

Bacterial growth; Escherichia coli; Nosocomial urinary tract infection; Trauma patients

Indexed keywords

AMINO ACID; IRON;

ADULT; AMINO ACID URINE LEVEL; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GLUCOSURIA; HUMAN; IRON URINE LEVEL; MALE; NONHUMAN; ONCOTIC PRESSURE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; URINALYSIS; URINARY TRACT INFECTION;

ADULT; CRITICAL ILLNESS; ESCHERICHIA COLI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; URINE; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84870057516     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-330     Document Type: Article

References (40)

1. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000, 28(1):68-75. 10.1016/S0196-6553(00)90015-4, 10679141.
2. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect 2005, 60(1):40-45. 10.1016/j.jhin.2004.09.038, 15823655.
3. Graves N, Weinhold D, Tong E, Birrell F, Doidge S, Ramritu P, Halton K, Lairson D, Whitby M. Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol 2007, 28(3):280-292. 10.1086/512642, 17326018.
4. Bagshaw SM, Laupland KB. Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis 2006, 19(1):67-71. 10.1097/01.qco.0000200292.37909.e0, 16374221.
5. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002, 23(1):27-31. 10.1086/501964, 11868889.
6. Rosser CJ, Bare RL, Meredith JW. Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg 1999, 177(4):287-290. 10.1016/S0002-9610(99)00048-3, 10326844.
7. Leone M, Albanese J, Garnier F, Sapin C, Barrau K, Bimar MC, Martin C. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med 2003, 29(7):1077-1080. 10.1007/s00134-003-1767-2, 12743682.
8. Stephan F, Yang K, Tankovic J, Soussy CJ, Dhonneur G, Duvaldestin P, Brochard L, Brun-Buisson C, Harf A, Delclaux C. Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Crit Care Med 2002, 30(2):315-322. 10.1097/00003246-200202000-00009, 11889301.
9. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HL. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 2004, 72(11):6373-6381. 10.1128/IAI.72.11.6373-6381.2004, 523057, 15501767.
10. Stamey TA, Mihara G. Observations on the growth of urethral and vaginal bacteria in sterile urine. J Urol 1980, 124(4):461-463.
11. Hull RA, Hull SI. Nutritional requirements for growth of uropathogenic Escherichia coli in human urine. Infect Immun 1997, 65(5):1960-1961. 175252, 9125589.
12. Lyte M, Ernst S. Catecholamine induced growth of gram negative bacteria. Life Sci 1992, 50(3):203-212. 10.1016/0024-3205(92)90273-R, 1731173.
13. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974, 14(3):187-196. 10.1097/00005373-197403000-00001, 4814394.
14. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270(24):2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22(7):707-710. 10.1007/BF01709751, 8844239.
16. Seligman PA, Schleicher RB. Comparison of methods used to measure serum iron in the presence of iron gluconate or iron dextran. Clin Chem 1999, 45(6 Pt 1):898-901.
17. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126(1):131-138. 10.1016/0003-2697(82)90118-X, 7181105.
18. Slocum RH, Cimmings JG. Amino acid analysis of physiological samples. Techniques in diagnostic human biochemical genetics, a laboratory manual 1991, 87-126. New-York: Wiley-Liss.
19. Pussard E, Neveux M, Guigueno N. Reference intervals for urinary catecholamines and metabolites from birth to adulthood. Clin Biochem 2009, 42(6):536-539. 10.1016/j.clinbiochem.2008.10.022, 19027729.
20. Moyer TP, Jiang NS, Tyce GM, Sheps SG. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin Chem 1979, 25(2):256-263.
21. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD, Warren JW. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 1990, 58(5):1281-1289. 258621, 2182540.
22. Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentre F, Wolff M, Denamur E, Branger C. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 2011, 17(4):557-565. 10.1111/j.1469-0691.2010.03298.x, 20649802.
23. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 2002, 18(5):465-470. 10.1097/00024382-200211000-00014, 12412628.
24. Porat R, Clark BD, Wolff SM, Dinarello CA. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 1991, 254(5030):430-432. 10.1126/science.1833820, 1833820.
25. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41(6):848-854. 10.1086/432803, 16107985.
26. Bonadio M, Boldrini E, Forotti G, Matteucci E, Vigna A, Mori S, Giampietro O. Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis 2004, 38(6):e41-e45. 10.1086/381755, 14999644.
27. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009, 37(5):1769-1776. 10.1097/CCM.0b013e3181a19ceb, 19325461.
28. Rowley D. Interrelationships between amino-acids in the growth of coliform organisms. J Gen Microbiol 1953, 9(1):37-43.
29. Anfora AT, Halladin DK, Haugen BJ, Welch RA. Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection. Infect Immun 2008, 76(12):5760-5767. 10.1128/IAI.00618-08, 2583553, 18838520.
30. Anfora AT, Haugen BJ, Roesch P, Redford P, Welch RA. Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun 2007, 75(11):5298-5304. 10.1128/IAI.00652-07, 2168303, 17785472.
31. Askanazi J, Michelsen CB, Carpentier YA, Elwyn DH, Gump FE, Kinney JM. Sequential changes in muscle and plasma amino acids during injury, infection, and convalescence. Surg Forum 1979, 30:90-92.
32. Barton R, Cerra FB. The hypermetabolism. Multiple organ failure syndrome. Chest 1989, 96(5):1153-1160. 10.1378/chest.96.5.1153, 2680321.
33. Verrey F, Singer D, Ramadan T, Vuille-dit-Bille RN, Mariotta L, Camargo SM. Kidney amino acid transport. Pflugers Arch 2009, 458(1):53-60. 10.1007/s00424-009-0638-2, 19184091.
34. Freund H, Atamian S, Holroyde J, Fischer JE. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979, 190(5):571-576. 10.1097/00000658-197911000-00003, 1344534, 389183.
35. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009, 361(1):62-72. 10.1056/NEJMra0801327, 19571284.
36. Kaye D. Antibacterial activity of human urine. J Clin Invest 1968, 47(10):2374-2390. 10.1172/JCI105921, 297400, 4877682.
37. Qualliotine D, DeChatelet LR, McCall CE, Cooper MR. Effect of catecholamines on the bactericidal activity of polymorphonuclear leukocytes. Infect Immun 1972, 6(3):211-217. 422518, 4564885.
38. Lyte M, Ernst S. Alpha and beta adrenergic receptor involvement in catecholamine-induced growth of gram-negative bacteria. Biochem Biophys Res Commun 1993, 190(2):447-452. 10.1006/bbrc.1993.1068, 8381276.
39. Freestone PP, Haigh RD, Lyte M. Blockade of catecholamine-induced growth by adrenergic and dopaminergic receptor antagonists in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. BMC Microbiol 2007, 7:8. 10.1186/1471-2180-7-8, 1800854, 17263883.
40. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007, 33(7):1285-1296. 10.1007/s00134-007-0656-5, 17487471.